Michael Kane, MD
Urology · Westminster, MDNPI 1710918057
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $1,313 of the $1,942 with a category attached, or 67.6%. Valencia Technologies Corporation accounts for 67.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2022 at $1,452 and has fallen 96.6% since, to $50 in 2025. That places this record below the midpoint for urology clinicians in MD, where the typical reported total is $4,190.
Across 22 payments — averaging $88.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Valencia Technologies Corporation$1K
- Astellas Pharma US Inc$184
- Lilly USA, LLC$122
- Teleflex LLC$97
- Tolmar, Inc.$55
- AbbVie$39
- plus $131 from 7 others
What the payments were for
- Travel & lodging$1,31368%
- Food & beverage$46124%
- Education$1679%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Valencia Technologies Corporation | 1 | $1,313 |
| Astellas Pharma US Inc | 4 | $184 |
| Lilly USA, LLC | 1 | $122 |
| Teleflex LLC | 4 | $97 |
| Tolmar, Inc. | 2 | $55 |
| AbbVie(2 entities) | 2 | $39 |
| 180 Medical, Inc. | 1 | $27 |
| Boston Scientific | 2 | $26 |
| Axonics, Inc. | 1 | $21 |
| Myriad Genetic Laboratories, Inc. | 1 | $18 |
| Neotract Inc. | 1 | $14 |
| Myovant Sciences Inc. | 1 | $13 |
| Tolmar Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- eCoin Device Kit$1,313
- MOUNJARO$122
How this compares
$1,942 in reported general payments places this provider in the 35th percentile of 274 urology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 152 | $122,175 |
| Tamsulosin Hcl | 498 | $7,410 |
| Trospium Chloride ErTrospium Chloride | 24 | $5,772 |
| Mirabegron ErMirabegron | 12 | $5,661 |
| Trospium Chloride | 80 | $5,276 |
| Dutasteride | 70 | $3,398 |
| Silodosin | 45 | $3,150 |
| Finasteride | 203 | $2,238 |
| Methenamine Hippurate | 20 | $2,186 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 61 | $1,787 |
| Estradiol | 15 | $1,585 |
| Darifenacin ErDarifenacin Hydrobromide | 15 | $1,358 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 39 | $624 |
| Solifenacin Succinate | 11 | $623 |
| NitrofurantoinNitrofurantoin Macrocrystal | 18 | $585 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $184 | $122,175152 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 274 urology providers in Maryland.
Other urology in Westminster
- Robert SegalWestminster$26K
- Matthew AllawayCumberland$20.6M
- Benjamin LowentrittBaltimore$549K
- Julio DavalosGlen Burnie$490K
- Sankar KausikBel Air$375K
- Laura GiustoOwings Mills$367K
- Amin HeratiBaltimore$160K
- Rian DicksteinHanover$144K
- Max KatesBaltimore$139K
- Arthur BurnettBaltimore$132K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.